Innovid Corp. Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements (Details) - Schedule of impact on revision of income statements - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021
As Previously Reported [Member]
Condensed Income Statements, Captions [Line Items]
Weighted average shares outstanding, Class A ordinary shares
Basic and diluted net income (loss) per Class A ordinary shares
Weighted average shares outstanding, Class B ordinary shares (non redeemable)	10,726,807	7,921,054	9,386,872
Basic and diluted net loss per ordinary shares (non redeemable)	$ (0.07)	$ (0.24)	$ (0.28)
Adjustment [Member]
Condensed Income Statements, Captions [Line Items]
Weighted average shares outstanding, Class A ordinary shares	25,300,000	12,087,778	18,730,387
Basic and diluted net income (loss) per Class A ordinary shares	$ (0.02)	$ 2.97	$ 1.88
Weighted average shares outstanding, Class B ordinary shares (non redeemable)	(4,401,807)	(2,026,887)	(3,276,099)
Basic and diluted net loss per ordinary shares (non redeemable)	$ 0.05	$ 0.14	$ 0.17
As Revised [Member]
Condensed Income Statements, Captions [Line Items]
Weighted average shares outstanding, Class A ordinary shares	25,300,000	12,087,778	18,730,387
Basic and diluted net income (loss) per Class A ordinary shares	$ (0.02)	$ 2.97	$ 1.88
Weighted average shares outstanding, Class B ordinary shares (non redeemable)	6,325,000	5,894,167	6,110,773
Basic and diluted net loss per ordinary shares (non redeemable)	$ (0.02)	$ (0.1)	$ (0.11)